Scynexis (SCYX) Gross Margin Growth (1y) (2014 - 2024)
Scynexis (SCYX) Gross Margin Growth (1y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 25,330.00 |
| Sep 30, 2024 | 2,152.00 |
| Jun 30, 2024 | 32.00 |
| Mar 31, 2024 | 1,212.00 |
| Dec 31, 2023 | -24,044.00 |
| Sep 30, 2023 | -938.00 |
| Jun 30, 2023 | 1,056.00 |
| Mar 31, 2023 | 202.00 |
| Dec 31, 2022 | 1,511.00 |
| Sep 30, 2022 | 1,596.00 |
| Mar 31, 2022 | -1,414.00 |
| Mar 31, 2015 | 8,570.00 |
| Dec 31, 2014 | 15,346.00 |
| Sep 30, 2014 | 117,277.00 |
| Jun 30, 2014 | 71,482.00 |
| Mar 31, 2014 | 234.00 |